{"nct_id":"NCT03909971","title":"A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2019-04-28","start_date_type":"ACTUAL","primary_completion_date":"2020-08-10","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-21","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}